68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Inclusion Criteria:

- Greater than 18 years-old at the time of radiotracer administration

- Provides written informed consent

- Known diagnosis of NET or suspected SSTR positive tumors by 111In-Octreotide scan,
18FDG-PET, or MRI of the abdomen when clinically indicated

- Karnofsky score greater than 50 or ECOG Performance Status 0-2

- Women of childbearing age must have a negative pregnancy test at screening/baseline

- Able to remain still for duration of each imaging procedure (about one hour)

Exclusion Criteria:

- Less than 18 years-old at the time of radiotracer administration

- Pregnant or nursing

- Serum creatinine >3.0 mg/dL

- Hepatic enzyme levels more than 5 times upper limit of normal.

- Use of any other investigational product or device within 30 days prior to dosing, or
known requirement for any other investigational agent prior to completion of all
scheduled study assessments.

- Inability to lie still for the entire imaging time

- Inability to complete the needed investigational and standard-of-care imaging
examinations due to other reasons (severe claustrophobia, radiation phobia, etc.)

- Any additional medical condition, serious intercurrent illness, or other extenuating
circumstance that, in the opinion of the Investigator, may significantly interfere
with study compliance.